REQUEST A DEMO
Total
USD $0.00
Search more companies

Namyang Pharm Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Namyang Pharm Co.,Ltd. Profile Updated: December 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Namyang Pharm Co.,Ltd. is an enterprise in South Korea, with the main office in Yangpyeong County. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on July 01, 1990. There are currently 80 (2024) people employed by Namyang Pharm Co.,Ltd.. There was a net sales revenue increase of 8.51% reported in Namyang Pharm Co.,Ltd.’s latest financial highlights for 2023. Its’ total assets recorded a growth of 4.04%. The enterprise’s net profit margin increased by 0.07% in 2023.

Headquarters
Yangpyeong-ro 30-gil Yeongdeungpo-gu Seoul, 22
Yangpyeong County; Gyeonggi;

Contact Details: Purchase the Namyang Pharm Co.,Ltd. report to view the information.

Website: http://www.nypharm.co.kr

Basic Information
Total Employees:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Incorporation Date:
July 01, 1990
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Subsidiaries
C&N Medical Inc
New Shin Pharm Co.,Ltd.
Tree Medical Co.,Ltd.
Company Performance
Financial values in the chart are available after Namyang Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.51%
Total operating revenue
8.51%
Operating profit (EBIT)
-4.24%
EBITDA
-3.46%
Net Profit (Loss) for the Period
15.3%
Total assets
4.04%
Total equity
7.04%
Operating Profit Margin (ROS)
-0.14%
Net Profit Margin
0.07%
Return on Equity (ROE)
0.75%
Debt to Equity Ratio
-19.06%
Quick Ratio
0.03%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?